GGrantIndex
Sort

51,593 grants matching hepatitis

Developmental Core

$558,190
John D Hamilton · Duke University · P30 · FY2011 · AI

Determinants of Liver Injury in Chronic Hepatitis C Virus Infection

$558,103
Detlef Schuppan · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI

Determinants of Liver Injury in Chronic Hepatitis C Virus Infection

$558,103
Detlef Schuppan · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI

The Lipid Protein Family and Triglyceride Metabolism

$558,075
Karen Reue · University Of California Los Angeles · P01 · FY2008 · HL

Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity

$558,074
Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI

Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD

$558,014
Jennifer R Havens · University Of Kentucky · R01 · FY2016 · DA

Human neural precursor cell-mediated therapy in a viral model of demyelination

$558,002
Thomas E Lane · University Of Utah · R01 · FY2018 · NS

Human neural precursor cell-mediated therapy in a viral model of demyelination

$558,002
Thomas E Lane · University Of Utah · R01 · FY2017 · NS

Human neural precursor cell-mediated therapy in a viral model of demyelination

$558,002
Thomas E Lane · University Of Utah · R01 · FY2016 · NS

Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD

$557,993
Madesh Muniswamy · University Of Texas Hlth Science Center · R01 · FY2023 · DK

HDAC1 as a nutrient sensor in the development and progression of NAFLD

$557,962
Hang Shi · Georgia State University · R01 · FY2025 · DK

Neutralizing Antibodies to Hepatitis C

$557,869
Steven Foung · Stanford University · R01 · FY2006 · HL

Nanochelation Therapies for Iron Overload Disorders

$557,866
Jonghan Kim · Northeastern University · R01 · FY2018 · HL

Molecular Organization of Renal and Hepatic Organic Cation Transporters

$557,859
Stephen H Wright · University Of Arizona · R01 · FY2013 · DK

Identification of Allsoteric Ligands for Hepatic Nuclear Factor 4-alpha

$557,846
Fraydoon Rastinejad · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · DK

Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function

$557,787
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AA

Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis

$557,780
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AA

Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis

$557,780
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AA

Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis

$557,780
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · AA

(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis

$557,736
David B Agus · University Of Southern California · R01 · FY2014 · CA

Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates

$557,732
Gerald I Shulman · Yale University · R01 · FY2019 · DK

Cytochrome P450-Endogenous Substrate Metabolism

$557,729
David J Waxman · Boston University (Charles River Campus) · R01 · FY2010 · DK

A Human-Centered Pharmacogenomic Screen of Metformin Action

$557,729
Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2015 · DK

Molecular Characterization of Joubert Syndrome

$557,723
Joseph G Gleeson · Rockefeller University · R01 · FY2016 · NS

HIV and Other Infectious Consequences of Substance Use

$557,680
Josiah D Rich · Miriam Hospital · T32 · FY2024 · DA